A New Approach to Treating Alzheimer's and Parkinson's is by reviving the Brain's Waste-Clearing System
FDA Green-Lights Second Alzheimer Drug, Donanemab
Alzheimer’s Association International Conference | July 27-31, 2025
Breaking Through Barriers: The Potential of Blood Tests for Alzheimer's Diagnosis
How Blood Biomarker Changes of Alzheimer's Impact Development of All-Cause Dementia - JAMA
How Do Changes in Blood Biomarkers of Alzheimer's Disease Impact the Development of All-Cause Dementia?
New JAMA Audio Update on latest Alzheimer Disease Medical News
Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug?
Aducanumab Combined With Focused Brain Ultrasound More Effective
Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons
Toward Gerineuropalliative Care for Patients with Dementia
MIND Diet No Better Than Control for Adults at Risk of Dementia
Ushering in a New Era of Alzheimer Disease Therapy
ALZHEIMER’S Solanezumab Preclinical Testing
Donanemab - July 17, 2023, Update
Eli Lilly Donanemab Slows Alzheimer’s
Green Tea + Other Molecules Uncover New Alzheimer’s Therapeutic Strategy
Alzheimer’s may increase DNA variants in brain neurons
Hydroxychloroquine lowers dementia risk in humans, improves molecular signs of Alzheimer’s in mouse
SENSE OF SMELL LINKED TO SPEED OF BRAIN LOSS AND COGNITIVE DECLINE